Products Antibodies Polyclonal Antibodies Anti-EIF2B1 Polyclonal Antibody for WB, IF/ICC, ELISA - Q14232
Anti-EIF2B1 Polyclonal Antibody for WB, IF/ICC, ELISA - Q14232

Polyclonal Antibodies

Anti-EIF2B1 Polyclonal Antibody for WB, IF/ICC, ELISA - Q14232

Item Number : CM0029132

Price varies based on specs and customizations


Application
WB, IF/ICC, ELISA
Cross Reactivity
Human, Mouse
Protein Weight
34kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name EIF2B1 Rabbit pAb
Remarks/Alias EIF2B; EIF2BA; EIF2Balpha; EIF2B1
Species Human
Gene ID (Human) 1967
Gene ID 1967
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-305 of human EIF2B1 (NP_001405.1).
Source Rabbit
Category Polyclonal Antibodies
Application WB, IF/ICC, ELISA
Cross Reactivity Human, Mouse
SWISS Q14232
Protein Weight 34kDa
Shipping Ice bag

Biological Background: EIF2B1 Function and Localization

  • EIF2B1 encodes the alpha subunit of the heteropentameric eIF2B complex, which functions as a guanine nucleotide exchange factor (GEF) for eukaryotic initiation factor 2 (eIF2).
  • The eIF2B complex catalyzes the exchange of GDP for GTP on the gamma subunit of eIF2, and this GEF activity is repressed when eIF2 alpha is phosphorylated, thereby coupling stress signals to global translation control. Related references: PMID:25858979, PMID:27023709, PMID:31048492
  • EIF2B1 is predominantly localized to the cytoplasm, specifically within the cytosol.
  • Alternative splicing of the EIF2B1 gene produces multiple transcript variants, which may translate into distinct protein isoforms.
  • The protein is subject to acetylation, a common post-translational modification that can influence protein function and stability.
  • Mutations in EIF2B subunit genes, including EIF2B1, are associated with leukodystrophy, a spectrum of neurodegenerative disorders.

Experimental Guidance and Technical Tips

  • The immunogen covers the N-terminal region (amino acids 1-305) of EIF2B1; expect detection of full-length protein and possibly N-terminal truncation variants.
  • In Western blot, the predicted molecular weight is approximately 34 kDa; validate the banding pattern in relevant human or mouse cell lysates considering potential isoform variation.
  • For immunofluorescence/ICC, optimize fixation and permeabilization conditions, as the cytoplasmic localization may require mild permeabilization protocols.
  • As a polyclonal antibody, it may detect multiple epitopes; include appropriate controls (e.g., knockdown lysates) to confirm specificity in your experimental system.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio is a dedicated IVD raw material partner offering one-stop access to validated antibodies, bulk reagents, and technical sourcing support for diagnostic development. For EIF2B1 and translation-related targets, we provide optimized polyclonal and monoclonal antibodies, ancillary reagents, and custom sourcing for rare targets to streamline your research and assay development.

View more faqs for this product

Product Datasheet

Anti-EIF2B1 Polyclonal Antibody for WB, IF/ICC, ELISA - Q14232


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!